表紙
市場調査レポート

心臓マーカー検査装置:医療機器のパイプライン評価

Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015

発行 GlobalData 商品コード 351354
出版日 ページ情報 英文 421 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
心臓マーカー検査装置:医療機器のパイプライン評価 Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015
出版日: 2016年01月05日 ページ情報: 英文 421 Pages
概要

当レポートでは、心臓マーカー検査装置のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における最近の出来事などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 心臓マーカー検査装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域 (国) 別
  • パイプライン製品:規制経路別
  • パイプライン製品:承認時期別 (推定)
  • 継続中の治験

第4章 心臓マーカー検査装置 - 開発中のパイプライン製品:企業別

  • 開発企業 - パイプライン製品:開発段階別
  • パイプライン製品:開発段階別

第5章 心臓マーカー検査装置の開発企業と製品の概要

  • 3PrimeDx, Inc.
  • Abbott Diagnostics
  • ACS Biomarker
  • Adaltis S.r.l.
  • AgPlus Diagnostics LTD
  • Alere Inc.
  • Alfa Scientific Designs, Inc.
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Alfa Wassermann, Inc.
  • Amdix B.V.
  • Analyticon Biotechnologies AG
  • Applied Proteomics, Inc.
  • Arrayit Diagnostics, Inc.
  • Astute Medical, Inc.
  • Aterovax SA
  • Axela Inc.
  • AXO Science S.A.S.
  • Beckman Coulter, Inc.
  • BG Medicine, Inc.
  • Biocartis SA
  • Biomarker Design Forschungs GmbH
  • bioMerieux S.A.
  • BiOracle Limited
  • Bio-Rad Laboratories, Inc.
  • Biouniversa s.r.l.
  • CardioGenics Inc.
  • Cavadis B.V.
  • Cellgenex Diagnostics
  • Centice Corporation
  • Children's Hospital Boston
  • China Medical Technologies, Inc.
  • China Sky One Medical, Inc.
  • Cleveland HeartLab, Inc.
  • Co-Diagnostics HBDC, Inc.
  • CompanDX Ltd.
  • Corgenix Medical Corporation
  • Corgenix, Inc.
  • Coris BioConcept
  • Courtagen Life Sciences, Inc.
  • CPD, LLC
  • Critical Diagnostics
  • DestiNA Genomics Ltd
  • diaDexus, Inc. (Inactive)
  • Diagnoptics Technologies B.V.
  • DiaPat GmbH
  • ELITech Group
  • EnCare Biotech B.V.
  • Firalis SAS
  • Fundacio Clinic per a la Recerca Biomedica
  • Gamma Therapeutics, Inc.
  • GeneNews Limited
  • Genesis Detection Systems, Inc.
  • Global Genomics Group, LLC
  • Grifols, S.A.
  • Hannover Medical School
  • Hospices Civils de Lyon
  • IMMUNARRAY LTD.
  • Immunodiagnostic Systems Holdings plc
  • Infigo Diagnostics Ltd
  • infYnity biomarkers S.A.S.
  • Insilicos LLC
  • Institut National de la Sante et de la Recherche Medicale
  • iXensor Co. Ltd.
  • Kamiya Biomedical Company
  • KineMed, Inc.
  • King's College London
  • LipoScience, Inc.
  • Marshall University
  • Mayo Clinic.
  • Medical University of South Carolina
  • Mediomics, LLC
  • MedMira Inc.
  • MetaboGen AB
  • Metanomics Health GmbH
  • Mindray Medical International Limited
  • MMBiosensing, LLC
  • Nanosphere, Inc.
  • NorthShore University Health System
  • Nuclea Biotechnologies Inc.
  • One Drop Diagnostics
  • Oran Diagnostics, LLC
  • Oregon Health & Science University
  • Ortho-Clinical Diagnostics Inc.
  • Pacific Nanoscience, Inc.
  • Parque Cientifico de Madrid
  • Prevencio, LLC
  • Prognosys LLC
  • Pronota NV
  • Proof Centre of Excellence
  • Proplex Technologies, Llc
  • Proteome Sciences Plc
  • QLIDA Diagnostics
  • Quest Diagnostics Incorporated
  • Radiometer Medical ApS
  • Randox Laboratories Limited
  • Rheonix, Inc.
  • Rice University
  • RMIT University
  • Rna Diagnostics Inc.
  • Roche Diagnostics International Ltd.
  • ROS Technologies, Inc
  • Rosetta Genomics, Ltd.
  • SATT South East
  • Siemens Healthcare Diagnostics Inc.
  • Singulex, Inc.
  • Skyline Diagnostics BV
  • SomaLogic, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Tcoag Us Inc
  • Tethys Bioscience, Inc.
  • The Johns Hopkins University
  • The Pennsylvania State University
  • The University of Adelaide
  • The University of Tokyo
  • Thermo Fisher Scientific Inc.
  • ThreeFold Sensors (Inactive)
  • TissueNetix, Inc.
  • Toshiba Medical Systems Corporation
  • Tosoh Bioscience, Inc.
  • True Diagnostics, Inc.
  • Universite de Montreal
  • University College Dublin
  • University of California, San Diego
  • University of California, San Francisco
  • University of Colorado
  • University of Illinois
  • University of Nebraska
  • University of Oslo
  • University of Otago
  • University of Texas Medical Branch at Galveston
  • Vaiomer, SAS
  • Vanderbilt University
  • VEGA Ltd
  • Vermillion, Inc.
  • Vital Diagnostics, Inc.
  • Warnex Inc. (Inactive)
  • Washington University School of Medicine

第6章 心臓マーカー検査装置 - 最近の出来事

第7章 付録

目次
Product Code: GDME0149EPD

GlobalData's Medical Devices sector report, "Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiac Markers Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Markers Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiac Markers Tests Overview

3. Products under Development

  • 3.1. Cardiac Markers Tests - Pipeline Products by Stage of Development
  • 3.2. Cardiac Markers Tests - Pipeline Products by Segment
  • 3.3. Cardiac Markers Tests - Pipeline Products by Territory
  • 3.4. Cardiac Markers Tests - Pipeline Products by Regulatory Path
  • 3.5. Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiac Markers Tests - Ongoing Clinical Trials

4. Cardiac Markers Tests - Pipeline Products under Development by Companies

  • 4.1. Cardiac Markers Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiac Markers Tests - Pipeline Products by Stage of Development

5. Cardiac Markers Tests Companies and Product Overview

  • 5.1. 3PrimeDx, Inc. Company Overview
  • 5.2. Abbott Diagnostics Company Overview
  • 5.3. ACS Biomarker Company Overview
  • 5.4. Adaltis S.r.l. Company Overview
  • 5.5. AgPlus Diagnostics LTD Company Overview
  • 5.6. Alere Inc. Company Overview
  • 5.7. Alfa Scientific Designs, Inc. Company Overview
  • 5.8. Alfa Wassermann Diagnostic Technologies, LLC Company Overview
  • 5.9. Alfa Wassermann, Inc. Company Overview
  • 5.10. Amdix B.V. Company Overview
  • 5.11. Analyticon Biotechnologies AG Company Overview
  • 5.12. Applied Proteomics, Inc. Company Overview
  • 5.13. Arrayit Diagnostics, Inc. Company Overview
  • 5.14. Astute Medical, Inc. Company Overview
  • 5.15. Aterovax SA Company Overview
  • 5.16. Axela Inc. Company Overview
  • 5.17. AXO Science S.A.S. Company Overview
  • 5.18. Beckman Coulter, Inc. Company Overview
  • 5.19. BG Medicine, Inc. Company Overview
  • 5.20. Biocartis SA Company Overview
  • 5.21. Biomarker Design Forschungs GmbH Company Overview
  • 5.22. bioMerieux S.A. Company Overview
  • 5.23. BiOracle Limited Company Overview
  • 5.24. Bio-Rad Laboratories, Inc. Company Overview
  • 5.25. Biouniversa s.r.l. Company Overview
  • 5.26. CardioGenics Inc. Company Overview
  • 5.27. Cavadis B.V. Company Overview
  • 5.28. Cellgenex Diagnostics Company Overview
  • 5.29. Centice Corporation Company Overview
  • 5.30. Children's Hospital Boston Company Overview
  • 5.31. China Medical Technologies, Inc. Company Overview
  • 5.32. China Sky One Medical, Inc. Company Overview
  • 5.33. Cleveland HeartLab, Inc. Company Overview
  • 5.34. Co-Diagnostics HBDC, Inc. Company Overview
  • 5.35. CompanDX Ltd. Company Overview
  • 5.36. Corgenix Medical Corporation Company Overview
  • 5.37. Corgenix, Inc. Company Overview
  • 5.38. Coris BioConcept Company Overview
  • 5.39. Courtagen Life Sciences, Inc. Company Overview
  • 5.40. CPD, LLC Company Overview
  • 5.41. Critical Diagnostics Company Overview
  • 5.42. DestiNA Genomics Ltd Company Overview
  • 5.43. diaDexus, Inc. (Inactive) Company Overview
  • 5.44. Diagnoptics Technologies B.V. Company Overview
  • 5.45. DiaPat GmbH Company Overview
  • 5.46. ELITech Group Company Overview
  • 5.47. EnCare Biotech B.V. Company Overview
  • 5.48. Firalis SAS Company Overview
  • 5.49. Fundacio Clinic per a la Recerca Biomedica Company Overview
  • 5.50. Gamma Therapeutics, Inc. Company Overview
  • 5.51. GeneNews Limited Company Overview
  • 5.52. Genesis Detection Systems, Inc. Company Overview
  • 5.53. Global Genomics Group, LLC Company Overview
  • 5.54. Grifols, S.A. Company Overview
  • 5.55. Hannover Medical School Company Overview
  • 5.56. Hospices Civils de Lyon Company Overview
  • 5.57. IMMUNARRAY LTD. Company Overview
  • 5.58. Immunodiagnostic Systems Holdings plc Company Overview
  • 5.59. Infigo Diagnostics Ltd Company Overview
  • 5.60. infYnity biomarkers S.A.S. Company Overview
  • 5.61. Insilicos LLC Company Overview
  • 5.62. Institut National de la Sante et de la Recherche Medicale Company Overview
  • 5.63. iXensor Co. Ltd. Company Overview
  • 5.64. Kamiya Biomedical Company Company Overview
  • 5.65. KineMed, Inc. Company Overview
  • 5.66. King's College London Company Overview
  • 5.67. LipoScience, Inc. Company Overview
  • 5.68. Marshall University Company Overview
  • 5.69. Mayo Clinic. Company Overview
  • 5.70. Medical University of South Carolina Company Overview
  • 5.71. Mediomics, LLC Company Overview
  • 5.72. MedMira Inc. Company Overview
  • 5.73. MetaboGen AB Company Overview
  • 5.74. Metanomics Health GmbH Company Overview
  • 5.75. Mindray Medical International Limited Company Overview
  • 5.76. MMBiosensing, LLC Company Overview
  • 5.77. Nanosphere, Inc. Company Overview
  • 5.78. NorthShore University Health System Company Overview
  • 5.79. Nuclea Biotechnologies Inc. Company Overview
  • 5.80. One Drop Diagnostics Company Overview
  • 5.81. Oran Diagnostics, LLC Company Overview
  • 5.82. Oregon Health & Science University Company Overview
  • 5.83. Ortho-Clinical Diagnostics Inc. Company Overview
  • 5.84. Pacific Nanoscience, Inc. Company Overview
  • 5.85. Parque Cientifico de Madrid Company Overview
  • 5.86. Prevencio, LLC Company Overview
  • 5.87. Prognosys LLC Company Overview
  • 5.88. Pronota NV Company Overview
  • 5.89. Proof Centre of Excellence Company Overview
  • 5.90. Proplex Technologies, Llc Company Overview
  • 5.91. Proteome Sciences Plc Company Overview
  • 5.92. QLIDA Diagnostics Company Overview
  • 5.93. Quest Diagnostics Incorporated Company Overview
  • 5.94. Radiometer Medical ApS Company Overview
  • 5.95. Randox Laboratories Limited Company Overview
  • 5.96. Rheonix, Inc. Company Overview
  • 5.97. Rice University Company Overview
  • 5.98. RMIT University Company Overview
  • 5.99. Rna Diagnostics Inc. Company Overview
  • 5.100. Roche Diagnostics International Ltd. Company Overview
  • 5.101. ROS Technologies, Inc Company Overview
  • 5.102. Rosetta Genomics, Ltd. Company Overview
  • 5.103. SATT South East Company Overview
  • 5.104. Siemens Healthcare Diagnostics Inc. Company Overview
  • 5.105. Singulex, Inc. Company Overview
  • 5.106. Skyline Diagnostics BV Company Overview
  • 5.107. SomaLogic, Inc. Company Overview
  • 5.108. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.109. Tcoag Us Inc Company Overview
  • 5.110. Tethys Bioscience, Inc. Company Overview
  • 5.111. The Johns Hopkins University Company Overview
  • 5.112. The Pennsylvania State University Company Overview
  • 5.113. The University of Adelaide Company Overview
  • 5.114. The University of Tokyo Company Overview
  • 5.115. Thermo Fisher Scientific Inc. Company Overview
  • 5.116. ThreeFold Sensors (Inactive) Company Overview
  • 5.117. TissueNetix, Inc. Company Overview
  • 5.118. Toshiba Medical Systems Corporation Company Overview
  • 5.119. Tosoh Bioscience, Inc. Company Overview
  • 5.120. True Diagnostics, Inc. Company Overview
  • 5.121. Universite de Montreal Company Overview
  • 5.122. University College Dublin Company Overview
  • 5.123. University of California, San Diego Company Overview
  • 5.124. University of California, San Francisco Company Overview
  • 5.125. University of Colorado Company Overview
  • 5.126. University of Illinois Company Overview
  • 5.127. University of Nebraska Company Overview
  • 5.128. University of Oslo Company Overview
  • 5.129. University of Otago Company Overview
  • 5.130. University of Texas Medical Branch at Galveston Company Overview
  • 5.131. Vaiomer, SAS Company Overview
  • 5.132. Vanderbilt University Company Overview
  • 5.133. VEGA Ltd Company Overview
  • 5.134. Vermillion, Inc. Company Overview
  • 5.135. Vital Diagnostics, Inc. Company Overview
  • 5.136. Warnex Inc. (Inactive) Company Overview
  • 5.137. Washington University School of Medicine Company Overview

6. Cardiac Markers Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiac Markers Tests - Pipeline Products by Stage of Development
  • Table 2: Cardiac Markers Tests - Pipeline Products by Segment
  • Table 3: Cardiac Markers Tests - Pipeline Products by Territory
  • Table 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Markers Tests - Ongoing Clinical Trials
  • Table 7: Cardiac Markers Tests Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Markers Tests - Pipeline Products by Stage of Development
  • Table 9: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: PulsePredic Test - Product Status
  • Table 11: PulsePredic Test - Product Description
  • Table 12: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status
  • Table 14: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description
  • Table 15: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status
  • Table 16: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description
  • Table 17: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Status
  • Table 18: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Description
  • Table 19: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
  • Table 20: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
  • Table 21: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status
  • Table 22: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description
  • Table 23: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
  • Table 24: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
  • Table 25: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status
  • Table 26: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description
  • Table 27: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status
  • Table 28: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description
  • Table 29: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Status
  • Table 30: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Description
  • Table 31: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status
  • Table 32: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description
  • Table 33: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Status
  • Table 34: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Description
  • Table 35: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Status
  • Table 36: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Description
  • Table 37: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status
  • Table 38: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description
  • Table 39: ARCHITECT i2000SR - NT Pro BNP Assay - Product Status
  • Table 40: ARCHITECT i2000SR - NT Pro BNP Assay - Product Description
  • Table 41: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Status
  • Table 42: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Description
  • Table 43: ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Multi-marker Heart Failure Assay - Product Status
  • Table 45: Multi-marker Heart Failure Assay - Product Description
  • Table 46: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: CLIAgen Cardiac Marker Assay - Product Status
  • Table 48: CLIAgen Cardiac Marker Assay - Product Description
  • Table 49: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: AgPlus Diagnostic System - Troponin I Assay - Product Status
  • Table 51: AgPlus Diagnostic System - Troponin I Assay - Product Description
  • Table 52: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Afinion hsCRP Assay - Product Status
  • Table 54: Afinion hsCRP Assay - Product Description
  • Table 55: Galectin-3 Test - Triage Meter Pro - Product Status
  • Table 56: Galectin-3 Test - Triage Meter Pro - Product Description
  • Table 57: Alfa Scientific Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Status
  • Table 59: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Description
  • Table 60: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: ACE Axcel System - Apo A1 Assay - Product Status
  • Table 62: ACE Axcel System - Apo A1 Assay - Product Description
  • Table 63: ACE Axcel System - Apo B Assay - Product Status
  • Table 64: ACE Axcel System - Apo B Assay - Product Description
  • Table 65: ACE Axcel System - HsCRP Assay - Product Status
  • Table 66: ACE Axcel System - HsCRP Assay - Product Description
  • Table 67: Alfa Wassermann, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status
  • Table 69: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description
  • Table 70: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status
  • Table 71: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description
  • Table 72: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Chitotriosidase Biomarker - Atherosclerosis - Product Status
  • Table 74: Chitotriosidase Biomarker - Atherosclerosis - Product Description
  • Table 75: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Turbitex APO A1 - Product Status
  • Table 77: Turbitex APO A1 - Product Description
  • Table 78: Turbitex APO B - Product Status
  • Table 79: Turbitex APO B - Product Description
  • Table 80: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: API Diagnostic Test - Cardiovascular Disease - Product Status
  • Table 82: API Diagnostic Test - Cardiovascular Disease - Product Description
  • Table 83: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Companion Diagnostic Test - Plavix - Product Status
  • Table 85: Companion Diagnostic Test - Plavix - Product Description
  • Table 86: Astute Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Diagnostic Test - Acute Coronary Syndrome - Product Status
  • Table 88: Diagnostic Test - Acute Coronary Syndrome - Product Description
  • Table 89: Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: AteroDx Combo - Product Status
  • Table 91: AteroDx Combo - Product Description
  • Table 92: AteroDx ISO - Product Status
  • Table 93: AteroDx ISO - Product Description
  • Table 94: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Status
  • Table 95: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Description
  • Table 96: Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: Cardiac Troponin Biomarker Kit - Product Status
  • Table 98: Cardiac Troponin Biomarker Kit - Product Description
  • Table 99: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: Multiplexed Detection - BNP - Product Status
  • Table 101: Multiplexed Detection - BNP - Product Description
  • Table 102: Multiplexed Detection - CRP - Product Status
  • Table 103: Multiplexed Detection - CRP - Product Description
  • Table 104: Multiplexed Detection - Myoglobin - Product Status
  • Table 105: Multiplexed Detection - Myoglobin - Product Description
  • Table 106: Multiplexed Detection - Troponin - Product Status
  • Table 107: Multiplexed Detection - Troponin - Product Description
  • Table 108: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Status
  • Table 110: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Description
  • Table 111: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Status
  • Table 112: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Description
  • Table 113: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Status
  • Table 114: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Description
  • Table 115: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status
  • Table 117: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description
  • Table 118: BGM Galectin-3 Test - Onset Heart Failure - Product Status
  • Table 119: BGM Galectin-3 Test - Onset Heart Failure - Product Description
  • Table 120: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Biomarker Assay - Acute Cardiac Stress - Product Status
  • Table 122: Biomarker Assay - Acute Cardiac Stress - Product Description
  • Table 123: Biomarker Assay - Congestive Heart Failure - Product Status
  • Table 124: Biomarker Assay - Congestive Heart Failure - Product Description
  • Table 125: Evalution - Cardiac Assay - Product Status
  • Table 126: Evalution - Cardiac Assay - Product Description
  • Table 127: Biomarker Design Forschungs GmbH Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Cardiac Markers Tests - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Markers Tests - Pipeline Products by Segment
  • Figure 3: Cardiac Markers Tests - Pipeline Products by Territory
  • Figure 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path
  • Figure 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiac Markers Tests - Ongoing Clinical Trials
Back to Top